325 related articles for article (PubMed ID: 17436229)
1. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
[TBL] [Abstract][Full Text] [Related]
2. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
[No Abstract] [Full Text] [Related]
4. Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.
Yrjänäinen H; Hytönen J; Söderström KO; Oksi J; Hartiala K; Viljanen MK
Microbes Infect; 2006 Jul; 8(8):2044-51. PubMed ID: 16797205
[TBL] [Abstract][Full Text] [Related]
5. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
Stricker RB; Johnson L
J Infect Dis; 2008 May; 197(9):1352-3. PubMed ID: 18422450
[No Abstract] [Full Text] [Related]
6. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
[TBL] [Abstract][Full Text] [Related]
7. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis.
McSweegan E
J Infect Dis; 2007 Dec; 196(12):1866; author reply 1866-7. PubMed ID: 18190271
[No Abstract] [Full Text] [Related]
10. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.
Liegner KB
J Infect Dis; 2003 May; 187(10):1676; author reply 1676. PubMed ID: 12721952
[No Abstract] [Full Text] [Related]
11. Cytokines in the serum and brain in mice infected with distinct species of Lyme disease Borrelia.
Isogai E; Isogai H; Kimura K; Hayashi S; Kubota T; Nishikawa T; Nakane A; Fujii N
Microb Pathog; 1996 Dec; 21(6):413-9. PubMed ID: 8971682
[TBL] [Abstract][Full Text] [Related]
12. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.
Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T
J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084
[TBL] [Abstract][Full Text] [Related]
14. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J
Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316
[TBL] [Abstract][Full Text] [Related]
15. Short report: Association of macrophage inflammatory response and cell death after in vitro Borrelia burgdorferi infection with arthritis resistance.
Glickstein LJ; Coburn JL
Am J Trop Med Hyg; 2006 Nov; 75(5):964-7. PubMed ID: 17123997
[TBL] [Abstract][Full Text] [Related]
16. Effect of salivary gland extract from Ixodes ricinus ticks on the proliferation of Borrelia burgdorferi sensu stricto in vivo.
Machácková M; Oborník M; Kopecký J
Folia Parasitol (Praha); 2006 Jun; 53(2):153-8. PubMed ID: 16898130
[TBL] [Abstract][Full Text] [Related]
17. Generality of Post-Antimicrobial Treatment Persistence of
Hodzic E; Imai DM; Escobar E
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308087
[TBL] [Abstract][Full Text] [Related]
18. Genotype determines phenotype in experimental Lyme borreliosis.
Pachner AR; Dail D; Bai Y; Sondey M; Pak L; Narayan K; Cadavid D
Ann Neurol; 2004 Sep; 56(3):361-70. PubMed ID: 15349863
[TBL] [Abstract][Full Text] [Related]
19. Lyme disease: disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro.
Varde S; Wormser GP; Nowakowski J; Nadelman RB; Bittker S; Cooper D; Schwartz I
Conn Med; 1999 Oct; 63(10):589-91. PubMed ID: 10578549
[TBL] [Abstract][Full Text] [Related]
20. Differential acquired immune responsiveness to bacterial lipoproteins in Lyme disease-resistant and -susceptible mouse strains.
Ganapamo F; Dennis VA; Philipp MT
Eur J Immunol; 2003 Jul; 33(7):1934-40. PubMed ID: 12884859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
